Transgene Insertions by Map Location
Stock Center logo

Lists of BDSC transgenic insertions with sequence coordinates (release 6 sequence assembly) or cytological locations are available at the links below. Insertions in attP sites are excluded from these lists. For most insertions mapped to the sequence, the cytology is estimated using the FlyBase Cytological<==>Sequence map conversion table.

       List ALL relevant insertions
The links below list insertions at BDSC from all sources. See FlyBase for appropriate references for individual insertions. Please cite those who generated and analyzed these materials when publishing your own work with these and other BDSC stocks.
Chromosome or Arm 1 (X) 2L 2R 3L 3R 4 Y
       List ONLY Gene Disruption Project insertions
The links below provide access to all insertions at BDSC that were selected by the BDGP/Gene Disruption Project's pipeline.
     Primary References for BDGP/GDP screens and pipeline: Spradling et al. 1999, Bellen et al. 2004, Bellen et al., 2011, GDP Web Site
     Primary References for other screens made available to the GDP pipeline (several screens are unpublished): Torok et al. 1993 (lacW), Rørth 1996 (EP), Staudt et al. 2005 (EPg), Ring 2001 (5HPw[+], 3HPy[+]), Huet et al. 2002 (wHy), Thibault et al. 2004 (XP, PB, RB, WH), Hacker et al. 2003 (GAL4D,EYFP), Beinert et al. 2004 (Mae-UAS.6.11), Konev et al. 2003 (KV)
Chromosome or Arm 1 (X) 2L 2R 3L 3R 4  

A caution about insertion phenotype data: Most insertions from large-scale screens have not been characterized for lethality, sterility or other phenotypes when they are made available to the community. Phenotypes noted on these pages typically reflect BDSC's assessment of the presence or absence of a balancer in the stock when it was processed into the collection. The presence or proportion of balancers in these stocks can change over time, and in balanced lines, the identified insertion might not be responsible for the phenotype. Use caution when attributing function to genes based on insertions even when a lethal or sterile phenotype is classified as "verified". In many cases this means that the phenotype has been associated with the insertion by failure to complement a deficiency for the region of the insertion. In such cases the phenotype could be caused by a closedly linked mutation induced by transposition rather than by the identified insertion.